Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Device c. difficile nucleic acid amplification test assay
Regulation Description Microorganism differentiation and identification device.
Definition In vitro diagnostic test for the qualitative detection of toxigenic clostridium difficile nucleic acids isolated and purified from stool specimens obtained from symptomatic patients.
Product CodeOMN
Regulation Number 866.2660
Device Class 1


Premarket Reviews
ManufacturerDecision
Cepheid
  SUBSTANTIALLY EQUIVALENT - CLIA SUBMISSION 1
MERIDIAN CO., LTD.
  SUBSTANTIALLY EQUIVALENT - CLIA SUBMISSION 2

-
-